Skip to main content


  • Caption

Commissioning of UK Tails Management Facility

09 May 2019

Commissioning is continuing apace at a new Tails Management Facility (TMF) at Urenco’s UK site.

The responsible management of the by-product of our enrichment services – depleted uranium hexafluoride (UF6) or tails – is crucial to our commitment to uranium stewardship and sustainability.

Our subsidiary, Urenco ChemPlants Limited, is responsible for the construction, commissioning and operation of the TMF. At the facility we will convert tails to stable uranium oxide (U3O8) for long-term storage pending reuse or final disposal.

We are proud of the fact that during the construction of the TMF we achieved more than 7 million hours of safe working, making it one of the safest construction sites in the UK.

Operations at the TMF are planned to start in 2019.

Urenco’s 2018 Sustainability Report will be published on 6 June.

The film was made in collaboration with ITN Productions and the Chemical Industries Association as part of a programme called Solutions for our Future.


About Urenco

Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.

With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.


Sign up to our newsletter by entering your email address below.

Back to
the goals